Limei Yin

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 537 citations

Life Sciences, Biotechnology, Oncology +14

Global, regional, and national burden of female cancers in women of child-bearing age, 1990–2021: analysis of data from the global burden of disease study 2021

Ping Sun, Chang Yu, Limei Yin et al. · EClinicalMedicine · 2024 · 194 citations · Full text

Medicine, Health Sciences, Oncology +17

Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer

Limei Yin, Jianxin Xue, Rui Li et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 140 citations

Medicine, Oncology, Radiation Oncology +17

Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy

Jie Lan, Rui Li, Limei Yin et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 110 citations

Medicine, Oncology, Radiation Oncology +17

Fasudil inhibits vascular endothelial growth factor–induced angiogenesis<i>in vitro</i>and<i>in vivo</i>

Limei Yin, Ken‐ichirou Morishige, Toshifumi Takahashi et al. · Molecular Cancer Therapeutics · 2007 · 84 citations · Full text

Life Sciences, Cell Biology, Pharmacology +15